Riverwater Partners’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Buy
22,593
+322
+1% +$33K 0.64% 54
2026
Q1
$2.43M Buy
22,271
+908
+4% +$86.5K 0.81% 40
2025
Q4
$1.73M Buy
21,363
+362
+2% +$31.2K 0.67% 47
2025
Q3
$1.84M Sell
21,001
-8,174
-28% -$730K 0.76% 38
2025
Q2
$2.42M Sell
29,175
-38
-0.1% -$3.18K 1.14% 20
2025
Q1
$2.45M Sell
29,213
-1,563
-5% -$145K 1.26% 16
2024
Q4
$2.84M Sell
30,776
-925
-3% -$89K 1.38% 12
2024
Q3
$2.89M Buy
31,701
+24,401
+334% +$2.11M 1.43% 11
2024
Q2
$601K Sell
7,300
-804
-10% -$59.1K 0.45% 63
2024
Q1
$538K Sell
8,104
-112
-1% -$6.91K 0.4% 72
2023
Q4
$466K Buy
8,216
+198
+2% +$10.4K 0.37% 77
2023
Q3
$437K Buy
8,018
+3,564
+80% +$211K 0.4% 79
2023
Q2
$300K Hold
4,454
0.27% 127
2023
Q1
$229K Buy
4,454
+3
+0.1% +$146 0.21% 159
2022
Q4
$205K Buy
4,451
+86
+2% +$4.03K 0.17% 187
2022
Q3
$221K Sell
4,365
-2,765
-39% -$138K 0.22% 159
2022
Q2
$325K Buy
7,130
+2,205
+45% +$98.6K 0.33% 108
2022
Q1
$229K Buy
+4,925
New +$220K 0.38% 95

Other funds holding LMAT

Riverwater Partners's LMAT Position: Q2 2026 in Review

Riverwater Partners increased its LeMaitre Vascular (LMAT) stake by 1.4% in Q2 2026, buying an estimated $33K and bringing the position to 22,593 shares worth $2.17M. The position accounts for 0.64% of the portfolio, ranked #54.

Riverwater Partners first reported a position in LMAT in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.89M in Q3 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Riverwater Partners held 22,593 shares of LeMaitre Vascular worth $2.17M as of Q2 2026.
  • Riverwater Partners bought 322 LeMaitre Vascular shares in Q2 2026, an estimated $33K.
  • LeMaitre Vascular made up 0.64% of Riverwater Partners's portfolio in Q2 2026, its #54 holding.
  • Riverwater Partners first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 18 quarters since.
  • Riverwater Partners's LeMaitre Vascular position peaked at $2.89M in Q3 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.